Blueprint Medicines (BPMC) Stock Highlights

94.81 | +0.22%

2024-11-21 01:26:55

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates BLU-285, which targets KIT Exon 17 mutants and PDGFRa D842V, abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. Its other drug candidate is BLU 554 FOR Advanced Hepatocellular Carcinoma, and BLU-667 for Ret Mutations, Fusions, and Predicted Resistant Mutants.

Statistics

Range Today

92.66 95.01

Volume Today 543.58K

Range 1 Year

63.5 121.9

Volume 1 Year 180.89M

Range 3 Year

37.82 121.9

Volume 3 Year 518.82M

Range 10 Year

13.04 125.61

Volume 10 Year 1.21B

Highlights

Market Capitalization 6.41B (mid)

Floating Shares 62.83M

Current Price 94.81

Price To Earnings -48.84

Price To Revenue 14.82

Price To Book 20.43

Earnings Per Share -2.08

Payout Ratio 0%

Performance

Latest +0.22%

1 Month +10.53%

3 Months +0.67%

6 Months -9.59%

1 Year +48.86%

3 Years -13.27%

5 Years +23.76%

10 Years +305.17%

Benchmarks

Market Capitalization

31 / 368

Gross Profits

35 / 278

Total Revenue

56 / 300

Total Rank

274 / 368

Free Cashflow

334 / 352

Performance 5 years

105 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.